Berkeley, CA, United States of America

Justin M Virgili


 


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 162(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2009)
  • Berkeley, CA (US) (2012)

Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Justin M Virgili: Innovator in Condensation Aerosol Technology

Introduction

Justin M Virgili is a notable inventor based in Berkeley, CA (US). He has made significant contributions to the field of aerosol delivery systems, particularly in the development of devices that enhance the delivery of substances such as drugs. With a total of 2 patents, his work is recognized for its innovation and practical applications.

Latest Patents

Justin's latest patents focus on multiple dose condensation aerosol devices and methods of forming condensation aerosols. These patents disclose devices and methods for entraining a substance within an airflow. The condensation aerosol delivery devices are designed to consistently produce multiple doses of a substance, characterized by high purity and high yield. The particle size distribution is appropriate for pulmonary delivery, allowing for effective administration to users in a single dose.

Career Highlights

Justin M Virgili is currently associated with Alexza Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovation in drug delivery systems, aiming to improve patient outcomes through effective aerosol technologies.

Collaborations

Some of Justin's notable coworkers include Mathieu Herbette and Andrew J G Kelly. Their collaborative efforts contribute to the ongoing advancements in aerosol technology and drug delivery systems.

Conclusion

Justin M Virgili stands out as an influential inventor in the field of condensation aerosol technology. His patents and work at Alexza Pharmaceuticals, Inc. reflect his commitment to innovation and improving drug delivery methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…